Meitav Investment House’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Hold
14,516
0.02% 138
2025
Q4
$1.53M Sell
14,516
-9,278
-39% -$871K 0.02% 153
2025
Q3
$2M Buy
+23,794
New +$1.96M 0.03% 133
2025
Q1
Sell
-397,392
Closed -$39.5M 234
2024
Q4
$39.5M Buy
397,392
+394,273
+12,641% +$40.6M 0.67% 46
2024
Q3
$364K Sell
3,119
-325,858
-99% -$38.7M 0.01% 191
2024
Q2
$40.7M Buy
328,977
+45,095
+16% +$5.81M 0.73% 43
2024
Q1
$37.5M Sell
283,882
-14,849
-5% -$1.83M 0.73% 44
2023
Q4
$32.5M Buy
298,731
+289,971
+3,310% +$30.1M 0.48% 63
2023
Q3
$908K Sell
8,760
-1,246
-12% -$134K 0.01% 212
2023
Q2
$1.15M Sell
10,006
-427
-4% -$48.5K 0.02% 211
2023
Q1
$1.21M Sell
10,433
-1,191
-10% -$129K 0.02% 214
2022
Q4
$1.29M Buy
11,624
+4,292
+59% +$439K 0.02% 220
2022
Q3
$634K Buy
7,332
+52
+0.7% +$4.64K 0.01% 274
2022
Q2
$664K Hold
7,280
0.01% 263
2022
Q1
$599K Buy
+7,280
New +$574K 0.01% 303
2021
Q4
Sell
-8,577
Closed -$645K 403
2021
Q3
$645K Sell
8,577
-16,037
-65% -$1.22M 0.01% 287
2021
Q2
$1.92M Buy
24,614
+20,090
+444% +$1.49M 0.05% 184
2021
Q1
$335 Sell
4,524
-485
-10% -$35.8K 0.01% 311
2020
Q4
$387K Buy
5,009
+661
+15% +$50.6K 0.02% 313
2020
Q3
$341K Sell
4,348
-1,045
-19% -$81.9K 0.02% 310
2020
Q2
$392K Sell
5,393
-218,195
-98% -$16.4M 0.02% 257
2020
Q1
$16.4M Buy
+223,588
New +$17.6M 1.23% 27
2019
Q3
Sell
-5,871
Closed -$469K 467
2019
Q2
$469K Buy
+5,871
New +$450K 0.03% 249
2018
Q2
Sell
-20,661
Closed -$1.08M 441
2018
Q1
$1.08M Buy
+20,661
New +$1.12M 0.05% 151

Other funds holding MRK

Meitav Investment House's MRK Position: Q1 2026 in Review

Meitav Investment House held its Merck (MRK) position steady in Q1 2026 at 14,516 shares worth $1.75M. The position accounts for 0.02% of the portfolio, ranked #138.

Meitav Investment House first reported a position in MRK in Q1 2018 and has held it in 24 quarters since. The position peaked at $40.7M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Meitav Investment House held 14,516 shares of Merck worth $1.75M as of Q1 2026.
  • Meitav Investment House left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.02% of Meitav Investment House's portfolio in Q1 2026, its #138 holding.
  • Meitav Investment House first reported a position in Merck in Q1 2018 and has held it in 24 quarters since.
  • Meitav Investment House's Merck position peaked at $40.7M in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Meitav Investment House's 13F filing for Q1 2026, filed 29 Apr 2026.